Endothelial-coagulative biomarkers in smoking cessation

P. Caponnetto, C. Russo, A. DiMaria, J. B. Morjaria, S. Burton, F. Guarino, E. Basile, M. Proiti, R. Polosa (Catania, Italy; Southampton, United Kingdom)

Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Caponnetto, C. Russo, A. DiMaria, J. B. Morjaria, S. Burton, F. Guarino, E. Basile, M. Proiti, R. Polosa (Catania, Italy; Southampton, United Kingdom). Endothelial-coagulative biomarkers in smoking cessation. Eur Respir J 2010; 36: Suppl. 54, 2069

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Smoking cessation
Source: Respipedia Article
Year: 2018

Factors associated with smoking cessation in a smoking cessation unit
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011

The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008

Factors affecting the success of smoking cessation treatment in a smoking cessation clinic
Source: International Congress 2017 – Smoking cessation
Year: 2017

e-cigarettes for smoking cessation
Source: International Congress 2015 – E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing?
Year: 2015



Nonpharmacological smoking cessation interventions in clinical practice
Source: Eur Respir Rev 2008; 17: 187-191
Year: 2008



Results of the smoking cessation treatment in a specialized smoking cessation clinic
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Abundance of smoking cessation reasons in participants of smoking cessation clinic
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011

The impact of smoking habits and secondhand smoke exposure on smoking biomarkers
Source: Virtual Congress 2020 – Smoking disease landscape: from inflammation to lung function and comorbidities
Year: 2020


The role of smokers‘ beliefs on smoking cessation and relapse prevention
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008

Relapse rates following different types of medication treatment through a smoking cessation program
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment
Source: Eur Respir J, 56 (4) 2000098; 10.1183/13993003.00098-2020
Year: 2020



Role of counseling in tobacco smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Comparison of efficacy of two smoking cessation methods among doctors-active smokers
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010


Smoking cessation: can we obtain more than we do at present?
Source: Annual Congress 2006 - Smoking and COPD: will it ever vanish into smoke?
Year: 2006


HTR2A genetic variants as risk factors for cigarette smoking at an early age and relapse to smoking cessation treatment.
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Effects of smoking and smoking cessation on decline in pulmonary function
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012